Medical Center Lecture Series

 

 

 

Tuesday, January 8, 2019

Heart Talk
Mario Pascual, M.D.
Electrophysiology Medical Director
Allan S. Stewart, M.D., F.A.C.S.
Chief, Cardiac Surgery
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Miami, Florida


Tuesday, January 22, 2019

The Addiction Crisis & Solutions
Paul E. Keck, Jr., M.D.
President and CEO
Lindner Center of HOPE
Mason, Ohio


Tuesday, February 19, 2019

The Masters Athlete:
Emerging Sports Medicine Treatments
to Maintain an Active Lifestyle

James Voos, M.D.
Chair, Department of Orthopedic Surgery
Division Chief and Medical Director of Sports Medicine
University Hospitals Health Systems
Cleveland, Ohio


Tuesday, March 12, 2019

Treating Untreatable Cancer with
Uniquely Personalized Gene Therapy

Bruce Levine, Ph.D.
Director, Clinical Cell and Vaccine Production Facility
Abramson Cancer Center, Penn Medicine
Philadelphia, Pennsylvania


Tuesday, April 9, 2019

The Risks and Benefits
of Dietary Supplements

Bimal Ashar, M.D.
Executive Health
Johns Hopkins Hospital
Baltimore, Maryland

The Medical Center at Ocean Reef hosts a series of informative and entertaining lectures by leading members of the healthcare community during the winter and spring of each season. January is just around the corner and so is the 2019 Lecture Series! You'll find an article about the next lecture in the series below. For more information about the Lecture Series, email or call us at 305-367-2600. We look forward to seeing you this season!

All lectures begin at 5 p.m. at the Cultural Center Theater.

Lecture Series: Treating “Untreatable” Cancer with Uniquely Personalized Gene Therapy

render of DNA

Learn how modern medical technology is learning to treat “untreatable” cancer with personalized gene therapy at the next Medical Center Lecture Series presentation at 5 p.m. Tuesday, March 12.

This informative lecture, sponsored by the Medical Lecture Series and Healthnetwork Foundation, will be presented by Dr. Bruce Levine, Director of the University of Pennsylvania Abramson Cancer Center’s Clinical Cell and Vaccine Production Facility (CVPF) in Philadelphia. Through clinical patient trials, the CVPF develops and tests novel cell and gene therapies for genetic diseases, hematologic malignancies, tumors and infectious diseases. Using this technology, the facility can engineer personalized and enhanced immunity.

Dr. Levine, who founded the CVPF, has been issued 23 patents and co-authored more than 130 publications. He has been interviewed by the New York Times, Wall Street Journal, National Geographic, Forbes Magazine, the BBC and other international media outlets.

Cancer has touched everyone’s lives, and the CVPF is engineering new ways to treat it. We hope you will join us in the Cultural Center Theatre to learn about Dr. Levine and the advances his facility is making into cancer treatment. As with all lectures in the 2019 series, cocktails and light hors d’oeuvres will follow the lecture, when you will have the opportunity to meet Dr. Levine. For more information about this lecture and the remaining lectures in the 2019 Medical Center Lecture Series, click here.

Cancer Statistics at a Glance

  • The number of new cancer cases is expected to rise to 23.6 million per year by 2030.
  • Estimated national expenditures for cancer care in the United States were $147.3 billion in 2017. Costs are likely to increase as the population ages and more expensive treatments are adopted.
  • In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States alone.
  • The most common cancers in 2018 (listed in descending order) are breast, lung and bronchus, prostate, colon, rectal, skin melanoma, bladder, non-Hodgkins lymphoma, kidney and renal pelvis cancers, endometrial, leukemia, pancreatic, thyroid and liver.Source: National Cancer Institute

Support the Medical Center by shopping with AmazonSmile. It’s the same Amazon you know, but Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to the Medical Center. Your prices stay the same. Click here to learn more.